A distribution quality management framework overseeing GDP and PMS
First written in FY2023-Q2. 1 of 2 entries say "Advanced", first in FY2025-H1. Latest entry: FY2025-H1.
1 other company's latest entry also says "Advanced".
- FY2025-H1AdvancedAnnual report
「We believe that the CRO and PMS business acquired recently can be expected to expand based on the strong relationships of trust that our Group has developed with customers, including medical institutions and pharmaceutical companies, and that the resources and expertise related to CRO and PMS will make a significant contribution to strengthening the Group's clinical development, regulatory filing and PMS functions within its total supply chain.」
The acquisition of ArkMS has given concrete form to strengthening distribution quality and supply chain functions, including PMS. - FY2023-Q2First statedAnnual report
「In an organizational reform effective 1 October 2022, the company established the Distribution Quality Management Division. By placing at the company a function overseeing GDP compliance and PMS initiatives across the group, it aims to further strengthen group-wide pharmaceutical distribution quality management.」
Effective 1 October 2022, the company newly established the Distribution Quality Oversight Department and will put in place a quality management framework overseeing GDP compliance and PMS initiatives across the Group.